CN101632728A - Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier - Google Patents
Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier Download PDFInfo
- Publication number
- CN101632728A CN101632728A CN200810055436A CN200810055436A CN101632728A CN 101632728 A CN101632728 A CN 101632728A CN 200810055436 A CN200810055436 A CN 200810055436A CN 200810055436 A CN200810055436 A CN 200810055436A CN 101632728 A CN101632728 A CN 101632728A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- medicine composition
- lignum
- application
- santali albi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses application of a Chinese medicinal composition in preparing a medicament for protecting blood brain barrier. The Chinese medicinal composition comprises ginseng, leech, centipede, scorpion, ground beeltle, cicada slough, red paeony root, borneol and the like, and has the effects of invigorating Qi and activating blood, and dispersing blood stasis and dredging collateral. The Chinese medicinal composition has obvious curative effect of protecting the blood brain barrier and reducing serum S100B protein; and clinical experiments prove that the Chinese medicinal composition can effectively protect the blood brain barrier and is free from generating adverse reactions.
Description
Technical field
The present invention relates to a kind of new purposes of Chinese medicine composition, particularly, the present invention relates to the application of a kind of Chinese medicine composition in the medicine of preparation protection blood brain barrier, belong to the Chinese medicine application.
Background technology
Blood brain barrier (BBB) plays an important role aspect the central nervous system stability keeping, and there is the damage of blood brain barrier in serious diseases such as cerebral infarction, craniocerebral injury, cerebral hemorrhage, subarachnoid hemorrhage.
S100B albumen is that a kind of molecular mass is that the acid calcium of 21kDa is conjugated protein, mainly is present in star spongiocyte and the Scs, and central nervous system tissue and malignant melanoma cell are had high degree of specificity.Brain tissue impairment often destroys and blood-brain barrier damage with the mechanicalness brain cell behind the experiment confirm craniocerebral trauma, and central nervous system's progressive injuries such as cerebral blood flow and brain cell metabolic alterations all cause cell membrane integrity to be destroyed, thereby make S100B enter blood circulation, so S100B concentration can reflect the encephaloclastic order of severity in the peripheral blood.The above results is the S100B concentration of directly passing through clinically to detect in the periphery serum, provides reliable basis for assessing brain injury degree and evaluate its prognosis.Therefore, the plasma concentration that detects S100B blood plasma in theory is to estimate the first-selected clinical method of BBB integrity.The S100B serum levels increase important symbol for brain injury.Clinical lapse to and heal back and clinical treatment can provide directiveness act on of the proteic mensuration of S100B to judging cerebral infarction.
At present, for the damage of blood brain barrier, still do not have specific medicament both at home and abroad and treat.
The present invention is the improvement invention of carrying out on the basis of No. 01131203.3 and No. 200410048292.2 patent, quotes in full the content of this two patent documents record at this.The application of unexposed this Chinese medicine composition of above-mentioned two patents in the protection blood brain barrier.
Summary of the invention
The object of the invention provides the application of a kind of Chinese medicine composition in the medicine of preparation protection blood brain barrier, and described Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 3-10 Hirudo 3-11 Eupolyphaga Seu Steleophaga 5-10 Olibanum (system) 1-5 Radix Paeoniae Rubra 3-9 Lignum Dalbergiae Odoriferae 1-5
Lignum Santali Albi 1-5 Scorpio 3-9 Periostracum Cicadae 3-12 Scolopendra 1-3 Borneolum Syntheticum 1-7 Semen Ziziphi Spinosae (stir-fry) 3-10;
Preferably, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 10 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 7 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
Or:
Radix Ginseng 10 Hirudo 8 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 9 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
Or:
Radix Ginseng 6 Hirudo 11 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 3 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5;
The active component of above-mentioned Chinese medicine composition is made up of following ingredients:
The a mean diameter is less than Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga, Periostracum Cicadae and the Olibanum (processed) medicated powder of 100 μ m;
B Borneolum Syntheticum medicated powder;
The volatile oil that c is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi;
The alcohol-extracted extract of the alcohol extract of d Radix Ginseng after after concentrating with ethanol extraction;
The water extracted immersing paste that is condensed into behind the water extract after the Lignum Dalbergiae Odoriferae behind the e extraction composition c and water extract, Radix Paeoniae Rubra and the Semen Ziziphi Spinosae (parched) of Lignum Santali Albi medicinal residues decoct with water and the water extract filtration of the medicine residues of Radix Ginseng after the extraction ingredient d, the mixing.
The invention also discloses that to contain above-mentioned Chinese medicine composition be capsule, tablet, granule, powder, oral liquid or pill as the pharmaceutical preparation of active component.
The invention provides the application in this Chinese medicine composition preparation protection blood brain barrier medicine; be preferably this Chinese medicine composition preparation and reduce the application in the proteic medicine of S100B in the serum; be the content that medicine of the present invention can effectively reduce S100B in the serum; this will help patient's prognosis, and this also is a strong evidence of medicament protection blood brain barrier of the present invention.
In the Chinese medicine composition of the present invention, as the latin name of the crude drug of active component and processing method thereof from " Chinese medicine voluminous dictionary " (in July, 1977, front page, Shanghai science tech publishing house) and " Chinese pharmacopoeia (version in 2005, Chemical Industry Press).
Chinese medicine composition of the present invention can also be routinely extraction and preparation process, for example, the preparation technology of Fan Biting " pharmacy of Chinese materia medica " (Shanghai Science Press 1997 December the 1st edition) record, make the acceptable any conventional dosage form of pharmaceutics, for example capsule, tablet, granule, powder, oral liquid or pill etc.
In the application of the present invention, described Chinese medicine composition is capsule, tablet, granule, powder, oral liquid or pill, for above-mentioned dosage form can be realized, need when these dosage forms of preparation, to add the pharmacy acceptable auxiliary, for example: filler, disintegrating agent, lubricant, suspending agent, binding agent, sweeting agent, correctives, antiseptic, substrate etc.Filler comprises: starch, pregelatinized Starch, lactose, mannitol, chitin, microcrystalline Cellulose, sucrose etc.; Disintegrating agent comprises: starch, pregelatinized Starch, microcrystalline Cellulose, carboxymethyl starch sodium, crospolyvinylpyrrolidone, low-substituted hydroxypropyl cellulose, cross-linking sodium carboxymethyl cellulose etc.; Lubricant comprises: magnesium stearate, sodium lauryl sulphate, Pulvis Talci, silicon dioxide etc.; Suspending agent comprises: polyvinylpyrrolidone, microcrystalline Cellulose, sucrose, agar, hydroxypropyl emthylcellulose etc.; Binding agent comprises, starch slurry, polyvinylpyrrolidone, hydroxypropyl emthylcellulose etc.; Sweeting agent comprises: saccharin sodium, Aspartane, sucrose, cyclamate, enoxolone etc.; Correctives comprises: sweeting agent and various essence; Antiseptic comprises: parabens, benzoic acid, sodium benzoate, sorbic acid and its esters, benzalkonium bromide, fixed, the Folium eucalypti globueli (Eucalyptus globulus Labill.) wet goods of acetic acid chloroethene; Substrate comprises: PEG6000, PEG4000, insect wax etc.
Capsule of the present invention is preferably made by following preparation method: five kinds of Chinese medicine such as the Hirudo of said ratio, Scorpio, Periostracum Cicadae, Eupolyphaga Seu Steleophaga, Scolopendra cleaned, and oven drying at low temperature, standby; Lignum Santali Albi, Lignum Dalbergiae Odoriferae extract volatile oil, and medicinal residues and aqueous solution are standby; Radix Ginseng extracts secondary with 70% alcohol heating reflux, and 3 hours for the first time, 2 hours for the second time, merge extractive liquid, reclaimed ethanol to there not being the alcohol flavor; The medicinal residues of medicine residues of Radix Ginseng and Lignum Santali Albi, Lignum Dalbergiae Odoriferae merge with aqueous solution, add Radix Paeoniae Rubra, Semen Ziziphi Spinosae (stir-fry), decoct with water secondary, 3 hours for the first time, 2 hours for the second time, collecting decoction filters, and filtrate is concentrated into the clear paste that relative density is 1.20-1.25 (60 ℃), add above-mentioned panaxynol extract, mixing, cold drying is ground into fine powder; The five tastes such as Olibanum (system) and Hirudo are ground into fine powder altogether; The Borneolum Syntheticum porphyrize, with above-mentioned fine powder facing-up, mixing sprays into volatile oil respectively, and mixing incapsulates, promptly.
Perhaps, capsule of the present invention is preferably made by following preparation method:
A) weight ratio of crude drug is: Radix Ginseng 3-10 part, Hirudo 3-11 part, Eupolyphaga Seu Steleophaga 5-10 part, Olibanum (processed) 1-5 part, Radix Paeoniae Rubra 3-9 part, Lignum Dalbergiae Odoriferae 1-5 part, Lignum Santali Albi 1-5 part, Scorpio 3-9 part, Periostracum Cicadae 3-12 part, Scolopendra 1-3 part, Borneolum Syntheticum 1-7 part, Semen Ziziphi Spinosae (parched) 3-10 part;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
Perhaps, capsule of the present invention is preferably made by following preparation method:
A) weight ratio of crude drug is: Radix Ginseng 3-10 part, Hirudo 3-11 part, Eupolyphaga Seu Steleophaga 5-10 part, Olibanum (system) 1-5 part, Radix Paeoniae Rubra 3-9 part, Lignum Dalbergiae Odoriferae 1-5 part, Lignum Santali Albi 1-5 part, Scorpio 3-9 part, Periostracum Cicadae 3-12 part, Scolopendra 1-3 part, Borneolum Syntheticum 1-7 part, Semen Ziziphi Spinosae (parched) 3-10 part;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 100 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae decoct with water, after the water extract filters, extractum to be condensed into; Radix Ginseng with ethanol extraction after, reuse water extraction, alcohol extract are condensed into alcohol-extracted extract after reclaiming ethanol, the water extract filter with all water extract mixings after be condensed into the water extracted immersing paste, extractum directly is spray dried to spray powder;
D) preparation process:
The superfine powder flour is added in the Fluidbedgranulatingdrier with step c) gained spray drying powder, sprays solvent again and make granule; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make capsule behind the mixing.
The consumption of pharmaceutical composition of the present invention is converted to the weight of raw medicinal material, is each 0.8-3 gram, and take 2-4 every day, is preferably each 1.11-2.22 and restrains, and takes every day three times.
The specific embodiment
Embodiment 1:
A) the crude drug prescription is:
Radix Ginseng 39.6g Hirudo 72.6g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 19.8g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g;
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 30-40 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into 60 ℃, and to measure relative densities be 0.9～1.1 alcohol-extracted extract, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 0.9～1.1 clear paste, standby; D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that extracts by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, by the capsule filler filling, make 1000 capsules behind the mixing.
Amount of drug of the present invention for each 2-4 grain, is taken three times every day.
Embodiment 2
A) the crude drug prescription is:
Radix Ginseng 66g Hirudo 52.8g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 59.4g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes the medicated powder mean diameter less than 70-90 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into relative density and is determined as 1.0～1.05 alcohol-extracted extracts at 60 ℃, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 1.0～1.1 clear paste, standby;
D) preparation process:
In Fluidbedgranulatingdrier, add the superfine powder flour, again the step c) gained is extracted extractum and spray into granulation; The granule made through granulate, is added the Borneolum Syntheticum fine powder, spray into the volatile oil that is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi, preparation process is pressed into 1000 routinely.
Amount of drug of the present invention for each 2-4 sheet, is taken three times every day.
Embodiment 3: the preparation of pill
A) the crude drug prescription is:
Radix Ginseng 39.6g Hirudo 66g Eupolyphaga Seu Steleophaga 46.2g Olibanum (system) 13.2g
Radix Paeoniae Rubra 33g Lignum Dalbergiae Odoriferae 13.2g Lignum Santali Albi 13.2g Scorpio 46.2g
Periostracum Cicadae 46.2g Scolopendra 6.6g Borneolum Syntheticum 33g Semen Ziziphi Spinosae (stir-fry) 33g
B) pulverizing medicinal materials technology:
Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga and five kinds of worm medicines of Periostracum Cicadae are prepared burden by prescription through the Olibanum (processed) that cleans, washes after handling the back and cleaning the process of preparing Chinese medicine, pulverized by pulverizer, the medicated powder fineness reaches more than 80 orders; Medicated powder behind the coarse powder carries out micronizing through various superfine communication techniques, makes medicated powder mean diameter 10-20 μ m; Medical material to be pulverized is prepared burden after the cleaning, drying sterilization;
C) extract concentrated and drying process:
Reuse water extraction behind Lignum Dalbergiae Odoriferae and the Lignum Santali Albi elder generation extracting in water volatile oil, Radix Paeoniae Rubra and Semen Ziziphi Spinosae add suitable quantity of water and decoct secondary, and each 3 hours, merge the water extract, after the filtration, extractum to be condensed into; Radix Ginseng is with an amount of 70% ethanol extraction secondary, each 3 hours, merge extractive liquid,, reclaim ethanol to there not being the alcohol flavor, the reuse water extraction, alcohol extract is condensed into 60 ℃, and to measure relative densities be 0.9～1.0 alcohol-extracted extract, the water extract filter with above-mentioned all water extract mixings after be concentrated into 60 ℃ to measure relative densities be 1.0～1.1 clear paste, standby;
D) preparation process:
Preparation process is made 1000 pills routinely.
Amount of drug of the present invention for each 2-4 grain, is taken three times every day.
For illustrating the activity of Chinese medicine composition of the present invention to the S100B protein content in protection blood brain barrier and the reduction serum; carried out following test proving its curative effect with the capsule that makes by the foregoing description 1 method (to call medicine of the present invention in the following text), but it can not constitute any restriction to scope of the present invention.
Experimental example:
1 data and method
1.1 among the physical data 60 routine patients, be divided into matched group and treatment group at random, matched group 30 examples, wherein male 19 examples, women 11 examples; 18～79 years old age, average 47.5 years old, cerebral infarction 12 examples wherein, cerebral hemorrhage 10 examples, craniocerebral injury 8 examples.30 examples are organized in treatment, wherein male 19 examples, women 11 examples; 19～81 years old age, average 48.5 years old, cerebral infarction 11 examples wherein, cerebral hemorrhage 13 examples, craniocerebral injury 6 examples.
1.2 inclusion criteria all meets " all kinds of cerebrovascular disease diagnosis main points " middle cerebral infarction, cerebral hemorrhage and the craniocerebral injury diagnostic criteria of nineteen ninety-five " the 4th the cerebrovascular academic conference in the whole nation " formulation, and falls ill≤3.
1.3 exclusion standard is transient ischemic attack 1.; 2. Combination apoplexy; 3. stress digestive tract ulcer hemorrhage is arranged or severe complication is arranged, after one's own heart renal insufficiency, severe infections, hematopathy etc.; 4. the apoplexy medical history is arranged and leave over serious sequela person.
2 methods
2.1 Therapeutic Method
Matched group gives corresponding symptomatic treatment, and the conventional bed of Patients with Cerebral Infarction keeps free movement of the bowels, rationally controlling blood pressure is controlled cerebral edema, continues 3～5, prevent and treat each system's complication, and give XUESHUANTONG 0.45g and add 0.9% sodium chloride injection 250mL, 1 intravenous drip every day; Patients with sevious craniocerebral injury is actively taked dehydration and is used hormone therapy, the spiritedness symptom is used tranquilizer or frozen sleep, actively correct shock, use the generation of cimetidine prevention stress ulcer shock person is arranged, and use citicoline, cerebrolysin treatment, positive treatment combined injury; Patients with cerebral hemorrhage gives oxygen uptake according to the state of an illness, make its quiet rest, keep respiratory passage unblocked, close observation pupil, mind and vital sign, reduce intracranial pressure, control cerebral edema (selecting 20% mannitol or Glycerin Fructose, furosemide or albumin etc.) based on dehydration, the regulation and control blood pressure is kept water, electrolyte and acid-base balance, prevents and treats complication.Anti symptom treatment such as stress ulcer hemorrhage, cardiac insufficiency diabetes, infection, malnutrition.
The treatment group added on the basis of matched group with each 3 of medicine of the present invention, every day 3 times.4 weeks of treatment cycle.
2.2 the criterion of therapeutical effect recovery from illness: neurological deficits score reduces 91%-100%, 0 grade of invalid degree.Produce effects: neurological deficits score reduces 46%-90%, invalid degree 1-3 level.Effectively: neurological deficits score reduces 18%-45%.Invalid: neurological deficits score reduces less than 18% or dead.
Detect serum S100B protein content 2.3 index detection patient is admitted to hospital, treatment was checked after 1,2,4 weeks, detected conventional index simultaneously.
2.4 the statistical analysis technique technical data adopts χ
2The t check is adopted in check, dosage data, and relatively the level of significant difference is decided to be P＜0.05.
3 results
3.1 two groups of curative effects relatively
Two groups of curative effect comparative results see Table 1.For the craniocerebral injury that a variety of causes causes, the Primary Care total effective rate is 80%, adds with total effective rate behind the medicine of the present invention to be increased to 96.7%.
Table 1 liang group curative effect comparative result N (%)
Annotate:
*Compare P＜0.05 with matched group
By table 1 as seen, treatment group total effective rate is significantly higher than matched group (P＜0.05), and visible medicine of the present invention all has better therapeutic effect for the damage of the blood brain barrier that a variety of causes causes, can effectively protect blood brain barrier.
3.2 two groups of serum S100B protein levels relatively
Two groups of horizontal comparative results of serum albumin see Table 2; two groups of patients serum S100B protein levels do not have significant difference when being admitted to hospital; after treating for 1 week; treatment group patients serum S100B protein level promptly begins remarkable reduction; and matched group does not significantly reduce, and after the treatment all around, treatment group serum S100B protein level significantly is lower than the treatment group; as seen medicine of the present invention can effectively reduce Blood Brain Barrier (BBB) permeability patients serum S100B protein content, can effectively protect blood brain barrier.
The table 2 liang horizontal comparative result of group serum albumin
Annotate:
*Compared P＜0.05 same day with being admitted to hospital on the same group; # and matched group compare, P＜0.05
3.3 untoward reaction detects
Obvious adverse reaction does not all take place in treatment group and matched group, and as seen share medicine of the present invention can the significantly increasing medicament untoward reaction, and medicine promptly of the present invention does not have obvious adverse reaction in the protection blood brain barrier.
4 conclusions
Medicine of the present invention can effectively be protected blood brain barrier, reduces Blood Brain Barrier (BBB) permeability patients serum S100B protein content, and does not have obvious adverse reaction.
Claims (7)
1. the application of Chinese medicine composition in the medicine of preparation protection blood brain barrier is characterized in that this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 3-10 Hirudo 3-11 Eupolyphaga Seu Steleophaga 5-10 Olibanum (system) 1-5 Radix Paeoniae Rubra 3-9 Lignum Dalbergiae Odoriferae 1-5
Lignum Santali Albi 1-5 Scorpio 3-9 Periostracum Cicadae 3-12 Scolopendra 1-3 Borneolum Syntheticum 1-7 Semen Ziziphi Spinosae (stir-fry) 3-10.
2. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 10 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 7 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
3. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 10 Hirudo 8 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 9 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
4. application as claimed in claim 1 is characterized in that, this Chinese medicine composition is made by following bulk drugs:
Radix Ginseng 6 Hirudo 11 Eupolyphaga Seu Steleophagas, 7 Olibanums (system) 2 Radix Paeoniae Rubra 5 Lignum Dalbergiae Odoriferaes 2
Lignum Santali Albi 2 Scorpios 3 Periostracum Cicadaes 7 Scolopendra 1 Borneolum Syntheticum, 5 Semen Ziziphi Spinosaes (stir-fry) 5.
5. as each described application among the claim 1-4, it is characterized in that the active component of described Chinese medicine composition is made up of following ingredients:
The a mean diameter is less than Scorpio, Hirudo, Scolopendra, Eupolyphaga Seu Steleophaga, Periostracum Cicadae and Olibanum (system) medicated powder of 100 μ m;
B Borneolum Syntheticum medicated powder;
The volatile oil that c is extracted by Lignum Dalbergiae Odoriferae and Lignum Santali Albi;
The alcohol-extracted extract of the alcohol extract of d Radix Ginseng after after concentrating with ethanol extraction;
The water extracted immersing paste that is condensed into behind the water extract after the Lignum Dalbergiae Odoriferae behind the e extraction composition c and water extract, Radix Paeoniae Rubra and the Semen Ziziphi Spinosae (stir-fry) of Lignum Santali Albi medicinal residues decoct with water and the water extract filtration of the medicine residues of Radix Ginseng after the extraction ingredient d, the mixing.
6. as each described application among the claim 1-4, it is characterized in that this Chinese medicine composition is capsule, tablet, granule, powder, oral liquid or pill as the pharmaceutical preparation of active component.
7, as each described application among the claim 1-4, it is characterized in that the application of this Chinese medicine composition in the proteic medicine of preparation attenuating serum S100B.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100554365A CN101632728B (en) | 2008-07-21 | 2008-07-21 | Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008100554365A CN101632728B (en) | 2008-07-21 | 2008-07-21 | Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101632728A true CN101632728A (en) | 2010-01-27 |
| CN101632728B CN101632728B (en) | 2013-08-07 |
Family
ID=41592165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008100554365A Active CN101632728B (en) | 2008-07-21 | 2008-07-21 | Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101632728B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020239356A1 (en) | 2019-05-27 | 2020-12-03 | Organes Tissus Regeneration Reparation Remplacement | Composition for the protection and repair of the blood brain barrier |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1124153C (en) * | 2001-08-31 | 2003-10-15 | 石家庄以岭药业股份有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1305490C (en) * | 2004-06-18 | 2007-03-21 | 河北以岭医药研究院有限公司 | Supermicro heart-meridians-activating Chinese medicine composition and its preparing method |
-
2008
- 2008-07-21 CN CN2008100554365A patent/CN101632728B/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020239356A1 (en) | 2019-05-27 | 2020-12-03 | Organes Tissus Regeneration Reparation Remplacement | Composition for the protection and repair of the blood brain barrier |
| FR3096579A1 (en) | 2019-05-27 | 2020-12-04 | Organes Tissus Regeneration Reparation Remplacement | composition for the protection and repair of the hematoencephalic barrier (BBB) |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101632728B (en) | 2013-08-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101683405B (en) | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing brain stroke | |
| CN101632728B (en) | Application of Chinese medicinal composition in preparing medicament for protecting blood brain barrier | |
| CN102145050A (en) | Application of traditional Chinese medicine composition for preparing drugs for preventing and treating post percutaneous coronary intervention (PCI) no-reflow | |
| CN101744906B (en) | Applications of Chinese medicinal composition in preparation of medicament for treating facial paralysis | |
| CN101683406B (en) | Application of a traditional Chinese medicine composition in preparation of medicament for treating and preventing hypertension | |
| CN101632727B (en) | Application of Chinese medicinal composition in preparing medicament for treating pulmonary hypertension | |
| CN101653489B (en) | Application of Chinese medicinal composition in preparation of medicament for preventing diabetes | |
| CN101632730B (en) | Application of Chinese medicinal composition in preparing medicament for treating affective disorder | |
| CN101590173B (en) | Application of traditional Chinese medicine composition in preparing medicine for treating hypertensive intracerebral hemorrhage | |
| CN102743456B (en) | The application of a kind of Chinese medicine composition in the medicine of preparation control delayed encephalopathy after acute carbon monoxide poisoning | |
| CN101590124B (en) | Application of traditional Chinese medicine composition in preparing medicament for improving prognosis of myocardial infarction | |
| CN101254248A (en) | Applications of Chinese medicinal composition for preparing medicament for curing chronic fatigue syndrome medicament | |
| CN101439116B (en) | Use of Chinese medicinal composition in preparing medicament for treating diabetes mellitus induced erectile dysfunction | |
| CN101744905B (en) | Applications of Chinese medicinal composition in preparation of medicament for treating pulmonary heart disease | |
| CN102178758A (en) | Medicament for treating peripheral nerve of diabetes | |
| CN102210760A (en) | Application of Chinese medicinal component in preparation of medicament for treating chronic epididymitis | |
| CN101632729A (en) | Application of Chinese medicinal composition in preparing medicament for treating involution syndrome | |
| CN101683458B (en) | Application of a traditional Chinese medicine composition in preparation of medicament for treating vertigo | |
| CN101612217B (en) | Application of Chinese medicinal composition in preparation of medicaments for treating central serous chorioretinopathy | |
| CN101757153B (en) | Application of traditional Chinese medicine composition in preparation of medicines for treating kidney deficiency blood stasis type erectile dysfunction | |
| CN101653487B (en) | Application of Chinese medicinal composition in preparation of medicament for treating acute cerebral infarction | |
| CN101269142B (en) | Application of Chinese medicinal composition in preparing medicament for treating right bundle branch conduction block | |
| CN101564438B (en) | Application of Chinese medicinal composition in preparation of medicament for treating acute severe brain injury | |
| CN101744917B (en) | Applications of Chinese medicinal composition to preparation of medicament for improving hypertension nervous symptoms | |
| CN102451248B (en) | Application of traditional Chinese medicine composition in preparation of medicament for treating diabetic neuropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |